Save time and get answers to complex questions with AI chat
Motegrity ingredients?Patent expiration eu dabrafenib?Pramlintide fda approval date?Somatuline generic name?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for ilaris
Yes. Ilaris is a biologic medicine. It contains rilonacept, a biologic drug made from a protein-based construct designed to interfere with inflammation by acting as a decoy receptor for specific inflammatory signals.
Ilaris is not a monoclonal antibody. It is a receptor fusion protein (a decoy receptor) biologic rather than an antibody that binds a single target in the way monoclonal antibodies typically do.
Because Ilaris is biologic, it’s generally supplied and used as a specialized protein therapy (not a small-molecule pill). Biologics also tend to be regulated and manufactured under biologics-specific pathways, which matters for topics like biosimilar availability and substitution rules.
Other Questions About Ilaris :